Skip to content
Home/Companies/Pharma/NTC
NTC

NTC

Pharma·Italy·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns NTC?

NTC is currently owned by Wise Equity SGR through Wisequity V (2019 vintage), since 2022.

Hand-verified · updated 2026-07-19

Wise Equity SGR
Investor
Wise Equity SGR
Wisequity V · 2019 · Small-Mid Buyout

Key facts

HQItaly
SectorPharma
StatusActive
Websitentcpharma.com

More from Wisequity V

Other portfolio companies in the same fund.

Almac
Almac
Active
ConstructionItaly· 2022
Onetag
Onetag
Active
TMTUK· 2022
Selle Royal Group
Selle Royal Group
Active
ConsumerItaly· 2021
Special Flanges
Special Flanges
Active
IndustrialsItaly· 2021
Cantiere del Pardo
Cantiere del Pardo
Exited 2023
ConsumerItaly· 2020
to
Fi.Mo.Tec.
Active
IndustrialsItaly· 2020

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track NTC

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy NTC?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on NTC.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue